The ex-vivo frequencies of circulating tetramer specific CD8 T-cells in TB patients before therapy was lower than in LTBI subjects, but increased at four months after therapy to comparable percentages detected in subjects with LTBI; this pattern was consistently found for all tested tetramers. This evidence concerns the gene CD8A and tuberculosis.